News

COVID-19 and Influenza Vaccine Administration

Under the current Delaware Public Health Emergency, the Director of the Delaware Emergency Management Agency (DEMA) and the Director of the Division of Public Health (DPH) have issued two separate Joint Orders authorizing specified individuals to provide healthcare services involving the administration of COVID-19 and Influenza vaccinations. These orders are available below:

• Vaccine Qualified Personnel Order signed November 2, 2021
• Seasonal Influenza Vaccine Administration signed September 17, 2021

Objective and Function

The primary objective of the Delaware Board of Pharmacy is to promote, preserve, and protect the public health, safety, and welfare. To meet this objective, the Board

• maintains a registry of drug outlets that manufacture, produce, sell, and distribute drugs, medications, and other materials used to diagnose and prevent illness and disease and to treat injury
• monitors the outlets to ensure safe practices
• develops standards for professional competency
• promulgates rules and regulations
• adjudicates complaints against professionals and, when necessary, imposes disciplinary sanctions.

The Board issues licenses to pharmacists and pharmacy interns. It also licenses pharmacies (both in Delaware and elsewhere), pharmaceutical manufacturers and distributors, medical gas dispensers and retail businesses that sell non-controlled prescription drugs for veterinary use.

The Board’s statutory authority is in 24 Del. C., Chapter 25.

Meetings

Unless notified otherwise, the Board meets the third Wednesday of every month, with the exception of July and December. All meetings are open to the general public and are held in the Cannon Building, 861 Silver Lake Boulevard, in Dover. The meeting schedule is available at the State of Delaware public meeting calendar.

The Board/Commission may need to review and approve your application for licensure and will only review a complete application. A complete application includes your application and any documentation submitted through DELPROS and/or any documents submitted through the mail or email from third-parties. The Board/Commission will review your documentation at its next scheduled meeting.